U.S. Markets closed
  • S&P 500

    3,629.63
    -5.78 (-0.16%)
     
  • Dow 30

    29,872.41
    -173.83 (-0.58%)
     
  • Nasdaq

    12,094.40
    +57.62 (+0.48%)
     
  • Russell 2000

    1,844.41
    -9.12 (-0.49%)
     
  • Crude Oil

    45.75
    +0.84 (+1.87%)
     
  • Gold

    1,805.50
    +0.90 (+0.05%)
     
  • Silver

    23.38
    +0.08 (+0.34%)
     
  • EUR/USD

    1.1926
    +0.0030 (+0.2504%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.17
    -0.47 (-2.17%)
     
  • GBP/USD

    1.3390
    +0.0031 (+0.2330%)
     
  • USD/JPY

    104.4170
    -0.0630 (-0.0603%)
     
  • BTC-USD

    18,873.61
    -167.22 (-0.88%)
     
  • CMC Crypto 200

    372.63
    +2.12 (+0.57%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Atara Biotherapeutics: 3Q Earnings Snapshot

·1 min read

SOUTH SAN FRANCISCO, Calif. (AP) _ Atara Biotherapeutics Inc. (ATRA) on Monday reported a loss of $74.3 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 92 cents.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.

Atara Biotherapeutics shares have fallen 12% since the beginning of the year. In the final minutes of trading on Monday, shares hit $14.43, a climb of nearly 7% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA